DE602005015323D1 - Prostaglandinanaloga - Google Patents

Prostaglandinanaloga

Info

Publication number
DE602005015323D1
DE602005015323D1 DE602005015323T DE602005015323T DE602005015323D1 DE 602005015323 D1 DE602005015323 D1 DE 602005015323D1 DE 602005015323 T DE602005015323 T DE 602005015323T DE 602005015323 T DE602005015323 T DE 602005015323T DE 602005015323 D1 DE602005015323 D1 DE 602005015323D1
Authority
DE
Germany
Prior art keywords
prostaglandin
compounds
prodrug
useful
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005015323T
Other languages
English (en)
Inventor
David W Old
Danny T Dinh
Robert M Burk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of DE602005015323D1 publication Critical patent/DE602005015323D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08Oxygen atoms
    • C07D223/10Oxygen atoms attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE602005015323T 2004-07-02 2005-05-31 Prostaglandinanaloga Active DE602005015323D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58514204P 2004-07-02 2004-07-02
US60018004P 2004-08-09 2004-08-09
PCT/US2005/019408 WO2006014206A1 (en) 2004-07-02 2005-05-31 Prostaglandin analogs

Publications (1)

Publication Number Publication Date
DE602005015323D1 true DE602005015323D1 (de) 2009-08-20

Family

ID=34971749

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005015323T Active DE602005015323D1 (de) 2004-07-02 2005-05-31 Prostaglandinanaloga

Country Status (9)

Country Link
US (1) US7326698B2 (de)
EP (1) EP1765785B1 (de)
AT (1) ATE435853T1 (de)
AU (1) AU2005270229B2 (de)
CA (1) CA2571782C (de)
DE (1) DE602005015323D1 (de)
DK (1) DK1765785T3 (de)
ES (1) ES2327251T3 (de)
WO (1) WO2006014206A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7531533B2 (en) 2005-01-27 2009-05-12 Asahi Kasei Pharma Corporation 6-Membered heterocyclic compound and use thereof
BRPI0811306A2 (pt) 2007-05-08 2015-01-27 Nat Univ Corp Hamamatsu Ativador de célula t citotóxica compreendendo agonista ep4
IT1402047B1 (it) * 2010-10-19 2013-08-28 Cross Pharma Sa Uso del mexiprostil nel trattamento delle malattie infiammatorie intestinali

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2452536A1 (de) * 1974-11-06 1976-05-13 Hoechst Ag Pyrrolidone und verfahren zu ihrer herstellung
US4166452A (en) * 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
EP0020039A1 (de) * 1979-05-23 1980-12-10 Beecham Group Plc Imidazol-Derivate, ihre Herstellung und pharmazeutischen Zusammensetzungen
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US5034413A (en) * 1989-07-27 1991-07-23 Allergan, Inc. Intraocular pressure reducing 9,11-diacyl prostaglandins
US5028624A (en) * 1989-07-27 1991-07-02 Allergan, Inc. Intraocular pressure reducing 9,15-diacyl prostaglandins
CA2021316C (en) * 1989-07-27 2000-10-24 Ming Fai Chan Intraocular pressure reducing 11-acyl prostaglandins
US4994274A (en) * 1989-07-27 1991-02-19 Allergan, Inc. Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
JPH0586034A (ja) 1991-09-27 1993-04-06 Nippon Oil & Fats Co Ltd ヒドロキシル基含有ラクタム誘導体及びその製造方法
WO2002010139A1 (en) * 2000-08-01 2002-02-07 Pharmacia Corporation Hexahydro-7-1h-azepin-2-yl-haxanoic acid derivatives as inhibitors of inducible nitric oxide synthase
US6747037B1 (en) * 2003-06-06 2004-06-08 Allergan, Inc. Piperidinyl prostaglandin E analogs

Also Published As

Publication number Publication date
EP1765785B1 (de) 2009-07-08
ES2327251T3 (es) 2009-10-27
US20070054893A1 (en) 2007-03-08
DK1765785T3 (da) 2009-11-02
ATE435853T1 (de) 2009-07-15
WO2006014206A1 (en) 2006-02-09
US7326698B2 (en) 2008-02-05
CA2571782C (en) 2012-07-03
AU2005270229B2 (en) 2012-04-12
EP1765785A1 (de) 2007-03-28
AU2005270229A1 (en) 2006-02-09
CA2571782A1 (en) 2006-02-09

Similar Documents

Publication Publication Date Title
CY1110835T1 (el) Διφαινυλ παραγωγα και η χρηση τους στη θεραπεια της ηπατιτιδας c
NO20060408L (no) Fremgangsmate for a modulere kalsium ione-frigjorings- aktivert kalsium ionekanaler
HRP20090281T1 (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
ATE440603T1 (de) 8-hydroxychinolinderivate
ME01992B (me) Jedinjenje diarilhidantoina
WO2005110410A3 (en) Kinase inhibitors as therapeutic agents
EA200800760A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
EA201200669A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
DK1814848T3 (da) 2,3,4-substitueret-cyclopentanoner som terapeutiske midler
TW200728307A (en) Novel spirochromanone derivatives
EA200801199A1 (ru) Ингибиторы киназы
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
WO2007087395A3 (en) UNSATURATED mTOR INHIBITORS
WO2007084728A3 (en) 2-imino-benzimidazoles
MX2009003081A (es) Derivados de pirrola utiles para el tratamiento de enfermedades mediadas por citoquinas.
EA200800302A1 (ru) Применение производных и аналогов тиазола при лечении рака
CY1108729T1 (el) 3,11b-cis-διυδpotetpabenazinh για την θεραπευτικη αντιμετωπιση μιας πολλαπλασιαστικης νοσου ή φλεγμονωδους παθησης
ATE449776T1 (de) Pyrroloä2,3-cüpyridinderivate
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
WO2008008660A3 (en) Cyclopentane derivatives as antiglaucoma agents
BRPI0716643A2 (pt) amidas terapêuticas e compostos relacionados
DE602005007765D1 (de) Neue indol- oder benzimidazol-derivate
CR10199A (es) Derivados de benzimidazol
DE602005015323D1 (de) Prostaglandinanaloga

Legal Events

Date Code Title Description
8364 No opposition during term of opposition